IP Library Granted Patent US 11,185,656
Granted Patent B2
US 11,185,656 · App. 17/200,109 · Granted Nov 30, 2021

Pulsed pressure swing adsorption system and method

Inventors: Nicholas L. Oddo (Hilton Head Island, SC); Peter D. Fitchen (Ann Arbor, MI); Eugene H. Breniman (San Antonio, TX)
Assignee: Aires Medical LLC
A61M16/101A61M16/0003A61M16/0063A61M16/0093A61M16/20B01D53/047B01D53/0454B01D53/0476B01D2257/102B01D2259/40009
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,185,656
App. No.
17/200,109
Granted
Nov 30, 2021
Kind
B2
Abstract

A pressure swing adsorption (PSA) system and methods for controlling each PSA cycle performed by the PSA system to produce oxygen enriched gas during productive portions of a user breathing cycle, and to cease production of oxygen enriched gas during non-productive portions of the user breathing cycle, is provided. The PSA system synchronizes PSA cycle phases including adsorption and desorption phases with a user's individual inhalation and exhalation phases, on a breath by breath basis, such that each PSA cycle can be dynamically varied from a succeeding PSA cycle, in real time in response to variations in the user's breathing cycle. An oxygen delivery device including a breathing cycle sensor provides breathing cycle inputs to a controller for use with at least one algorithm to detect breathing flow phases during each user breath, and to synchronize each PSA cycle to the user's breathing flow phases, on a breath-by-breath basis.

Claims (54)

1. An oxygen concentrator system comprising:

a pressure swing adsorption (PSA) system including:

a gas outlet airline configured to flow oxygen enriched gas to a user of the oxygen concentrator;

wherein the PSA system is configured to execute a PSA cycle to produce the oxygen enriched gas;

a cannula configured to receive breathing gas from the user;

a sensor in communication with the cannula and the PSA system; wherein the sensor is configured to sense a breathing cycle of the user;

wherein:

the breathing cycle includes an inhalation phase and an exhalation phase;

the exhalation phase includes a non-useful period succeeded by a pre-inhalation period;

wherein each respective breath is immediately preceded in the breathing cycle by a preceding breath and is immediately succeeded in the breathing cycle by a succeeding breath;

wherein the cannula is configured such that carbon dioxide (CO2) rich gas output from the user during the exhalation phase of the preceding breath is not re-inhaled by the user during the inhalation phase of the succeeding breath; and

wherein the PSA system is configured to actuate a flow of the oxygen enriched gas via the gas outlet airline at the beginning of the pre-inhalation period of the exhalation phase.

2. The oxygen concentrator system of claim 1 , wherein:

the PSA cycle includes an adsorption phase and a desorption phase; and

the PSA system is configured to synchronize execution of the PSA cycle with the breathing cycle such that the adsorption phase is actuated at the beginning of the pre-inhalation period.

3. The oxygen concentrator system of claim 1 , wherein the gas outlet airline is a unidirectional airline configured to flow the oxygen enriched gas to the user.

4. The oxygen concentrator system of claim 1 , wherein the cannula is a bidirectional airline.

5. The oxygen concentrator system of claim 1 , wherein the sensor is located in the cannula.

6. The oxygen concentrator system of claim 1 , wherein the beginning of the pre-inhalation period is defined by at least one of an actual beginning or a predicted beginning of the pre-inhalation period.

7. The oxygen concentrator system of claim 1 , further comprising:

a controller in communication with the sensor, the controller is configured to:

receive breath parameter data from the sensor; and

determine, using the breath parameter data, an actual beginning of the pre-inhalation period; and

wherein the PSA system is configured to actuate the flow of the oxygen enriched gas via the gas outlet airline at the actual beginning of the pre-inhalation period.

8. The oxygen concentrator system of claim 1 , further comprising:

a controller in communication with the sensor, the controller is configured to:

receive breath parameter data from the sensor; and

determine, using the breath parameter data, a predicted beginning of the pre-inhalation period;

wherein the PSA system is configured to actuate the flow of the oxygen enriched gas via the gas outlet airline at the predicted beginning of the pre-inhalation period.

9. The oxygen concentrator system of claim 1 , wherein the PSA system is configured to output a positive end expiratory pressure (PEEP) to the user during the exhalation phase of the user.

10. The oxygen concentrator system of claim 9 , wherein the PSA system includes a plurality of microblowers actuable to output pressurized air via the gas outlet line.

11. An oxygen concentrator system comprising:

a pressure swing adsorption (PSA) system including:

a gas outlet configured to selectively flow oxygen enriched gas or pressurized air to a user of the oxygen concentrator;

wherein the PSA system is configured to execute a PSA cycle to produce the oxygen enriched gas;

a sensor in communication with the gas outlet and the PSA system;

wherein the sensor is configured to sense a breathing cycle of the user;

wherein the breathing cycle includes an inhalation phase and an exhalation phase;

wherein each respective breath is immediately preceded in the breathing cycle by a preceding breath and is immediately succeeded in the breathing cycle by a succeeding breath;

wherein:

the inhalation phase includes a useful period and a dead space period;

the dead space period occurs between the useful period and the exhalation phase;

wherein the PSA system is further configured to actuate a flow of the pressurized air via the gas outlet at the beginning of the dead space period of the inhalation phase; and

a cannula configured such that carbon dioxide (CO2) rich gas output from the user during the exhalation phase of the preceding breath is not re-inhaled by the user during the inhalation phase of the succeeding breath.

12. The oxygen concentrator system of claim 11 , wherein the PSA system is configured to flow oxygen enriched gas via the gas outlet at an actual beginning or at a predicted beginning of the inhalation phase of the user.

13. The oxygen concentrator system of claim 11 , wherein the at least one breathing parameter is the actual beginning or the predicted beginning of the inhalation phase of the user.

14. The oxygen concentrator system of claim 11 , wherein:

the PSA cycle includes an adsorption phase and a desorption phase; and

the controller is configured to synchronize execution of the PSA cycle with the at least one breathing parameter.

15. The oxygen concentrator system of claim 12 , further comprising:

a controller in communication with the sensor and the PSA system;

the controller configured to:

receive breathing parameter data from the sensor; and

determine at least one breathing parameter of the use in real time.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2025
From: BEECH HEALTH, INC.
To: EHRLICH CONSULTING GROUP, INC.
Reel/Frame 071205/0771 →
CHANGE OF NAME Recorded May 22, 2025
From: AIRES MEDICAL LLC
To: AIRES MEDICAL, INC.
Reel/Frame 071196/0555 →
CHANGE OF NAME Recorded May 22, 2025
From: AIRES MEDICAL, INC.
To: BEECH HEALTH, INC.
Reel/Frame 071349/0299 →
CORRECTION BY DECLARATION ERRONEOUSLY FILED AGAINST REEL/FRAME 062110/0481 ON DATE 12/15/2022 BY JOHN DOE Recorded Apr 1, 2025
From: AIRES MEDICAL LLC
To: AIRES MEDICAL LLC
Reel/Frame 070883/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2022
From: BEECH HEALTH, INC
To: GOLDMAN SEPHORIC LLC
Reel/Frame 062110/0481 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2021
From: ODDO, NICHOLAS L.; FITCHEN, PETER D.; BRENIMAN, EUGENE H.
To: AIRES MEDICAL LLC
Reel/Frame 055589/0620 →
Continuity (3)
Continuation 16704413 · Dec 5, 2019
Provisional Application 62775733 · Dec 5, 2018
Related Publication 20210196918A1 · Jul 1, 2021